5
项与 Anti-CD19 CAR-T cell therapy (Yake Biotechnology) 相关的临床试验Clinical Study of Targeting CD19-BAFF CAR-T Cells in the Treatment of Autoimmune Diseases
Clinical Trial for the safety and efficacy of CD19-BAFF CAR-T cells therapy for Autoimmune Diseases.
A Phase Ⅱ Clinical Study Evaluating the Efficacy and Safety of Human CD19 Targeted T Cells Injection (CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
A Phase Ⅱ Clinical Study Evaluating the Efficacy and Safety of Human CD19 Targeted T Cells Injection (CD19 CAR-T) Therapy for R/R B-NHL.
Patients will be given a conditioning chemotherapy regimen of fludarabine and cyclophosphamide followed by a single infusion of CD19 CAR+ T cells.
Clinical Trial for the Safety and Efficacy of Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions
Clinical trial for the safety and efficacy of sequential radiotherapy with CAR-T cells in the treatment of relapsed and refractory hematological malignancies with extramedullary lesions
100 项与 Anti-CD19 CAR-T cell therapy (Yake Biotechnology) 相关的临床结果
100 项与 Anti-CD19 CAR-T cell therapy (Yake Biotechnology) 相关的转化医学
100 项与 Anti-CD19 CAR-T cell therapy (Yake Biotechnology) 相关的专利(医药)
100 项与 Anti-CD19 CAR-T cell therapy (Yake Biotechnology) 相关的药物交易